Feed Preview

Fast Growing

Alzheimer's Disease: Abeta

Alzheimer's Disease: Abeta diagram by ellepigrafica, Shutterstock
ellepigrafica, Shutterstock

Alzheimer's disease (AD) is a chronic neurodegenerative disease associated with accumulation of amyloid plaques, which are comprised of amyloid beta. Here is the latest research in this field.

Top 20 most recent papers
Neurobiology of Aging

Determinants of mesial temporal lobe volume loss in older individuals with preserved cognition: a longitudinal PET amyloid study

Neurobiology of AgingFebruary 15, 2020
Marie-Louise MontandonPanteleimon Giannakopoulos
American Journal on Intellectual and Developmental Disabilities

The Search for Biomarkers of Alzheimer's Disease in Down Syndrome

American Journal on Intellectual and Developmental DisabilitiesFebruary 15, 2020
Benjamin L Handen
1
Annals of Neurology

Sleep deprivation affects tau phosphorylation in human cerebrospinal fluid

Annals of NeurologyFebruary 15, 2020
Nicolas R BarthélemyBrendan P Lucey
28
Nanotechnology

Impact nano- conjugate on Drosophila for early diagnosis of Alzheimer's disease

NanotechnologyFebruary 12, 2020
Aya Ahmed SaeedOla Sayed Ahmed
3
1
Neurobiology of Learning and Memory

Memory decline correlates with increased plasma cytokines in amyloid-beta (1-42) rat model of alzheimer's disease

Neurobiology of Learning and MemoryFebruary 16, 2020
Oluwadamilola F ShallieMusa V Mabandla
2
Acta Neuropathologica

Identification of early pericyte loss and vascular amyloidosis in Alzheimer's disease retina

Acta NeuropathologicaFebruary 12, 2020
Haoshen ShiMaya Koronyo-Hamaoui
16
1
bioRxiv

Reversal of β-amyloid induced microglial toxicity in vitro by activation of Fpr2/3

bioRxivFebruary 14, 2020
Edward S WicksteadSimon McArthur
7
Progress in Brain Research

Focusing on cellular biomarkers: The endo-lysosomal pathway in Down syndrome

Progress in Brain ResearchFebruary 15, 2020
Alexandra Botté, Marie-Claude Potier
CNS & Neurological Disorders Drug Targets

Scopolamine, a toxin-induced experimental model used for research in Alzheimer's disease

CNS & Neurological Disorders Drug TargetsFebruary 15, 2020
Win Ning Chen, Keng Yoon Yeong
Brain Sciences

Therapeutic Potential of Direct Clearance of the Amyloid-β in Alzheimer's Disease

Brain SciencesFebruary 14, 2020
Dong Eun Kim, Ronny Priefer
Cell Reports

Transcriptional Signatures of Tau and Amyloid Neuropathology

Cell ReportsFebruary 13, 2020
Isabel CastanhoJonathan Mill
50
5

See more papers from this feed

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/alzheimers-disease-abeta/04a02fd8-ebb8-4fd7-a5af-a23ea43ba447